22, 2026 (HealthDay News) With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes
This finding positioned GLP-1 receptor agonists not merely as metabolic drugs but as cardiovascular therapeutics, a distinction that carries particular relevance for menopausal women, whose cardiovascular risk accelerates significantly during and after the transition
In the context of GLP-1 medications, compounding pharmacies have become a significant part of the treatment space primarily due to two factors: the severe nationwide shortages of brand-name GLP-1 drugs that began in 2022 and persisted for years, and the extraordinary cost of these medications for patients without insurance coverage or with inadequate coverage
Categories such as lean protein, meal replacement, and healthier snack options have seen significant growth, while indulgent items like chips have declined
This represents substantial savings compared to American prices, which typically range from $1,000 to $1,200 USD monthly
Synthesis and evaluation of stearylated hyaluronic acid for the active delivery of liposomes to liver endothelial cells
)
